Alticast Achieves Both Financial Improvement and Earnings Rebound, Raising Expectations for Corporate Value Reassessment

Alticast announced on April 6 that it is working to restore market confidence by simultaneously achieving two goals: improving its financial structure and driving business growth. With listing requirements on the KOSDAQ market becoming stricter and oversight of low-priced stocks tightening, the company is being recognized for its proactive approach in establishing a foundation for listing stability and enhancing corporate value.

At its shareholders' meeting in March, Alticast confirmed a 5-for-1 reverse stock split. This measure aims to increase per-share value and strengthen financial stability by adjusting the number of shares, in response to stricter delisting regulations for penny stocks and companies at risk of capital impairment. As a result, the company is expected to shed its penny stock image and create a more stable trading environment favored by institutional and foreign investors.

Business performance is also visibly improving. In April last year, Alticast acquired Daehyeon Kigeon, a company specializing in HVAC and firefighting systems, thereby securing a solid earnings base. As a result, consolidated sales last year jumped 835% year-on-year to 53.2 billion won, and operating profit turned positive, reaching 3.2 billion won. The market is focusing on how the company broke out of its chronic deficit structure and established a stable financial base in the first year after the change in its largest shareholder.

Investments to secure new growth drivers are also ongoing. On March 25, its subsidiary Aptamer Science announced that it would acquire 100% of shares in Choolip Inc., a U.S. premium pet food company, for 17.2 billion won. This acquisition is expected to positively impact not only the value of the subsidiary, but also the equity value of Alticast as the parent company.

Choolip was founded in California by a Korean veterinarian and demonstrated its product competitiveness by ranking first in the new product showcase at the global pet industry exhibition 'SuperZoo 2024.' Aptamer Science plans to combine its proprietary biotechnology with Choolip's global distribution network to produce and sell functional premium pet food.

Currently, Choolip is available through major online and offline distributors such as Amazon and Costco, and plans to expand to Walmart (500–900 stores), TJ Maxx (5,000 stores), Petco (1,300 stores), and Target (500 stores) within this year.

According to market research firm Mordor Intelligence, the global premium pet food market is expected to grow at an average annual rate of 8% through 2030. Accordingly, this acquisition is projected to positively influence Alticast's mid- to long-term investment returns and corporate value reassessment.

An Alticast official stated, "By conducting the reverse stock split and transferring paid-in capital in excess of par value to retained earnings, we have established a foundation for listing stability and enhancement of shareholder value," adding, "By combining Daehyeon Kigeon's stable cash generation with the growth potential of Aptamer Science, we have built a portfolio for strengthening corporate value."

The official further emphasized, "Based on solid business results and increased subsidiary investment value, we expect to establish ourselves as a leading company within the next two to three years."

This content was produced with the assistance of AI translation services.